Literature DB >> 20884058

Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.

Flavio E Hirai1, James M Tielsch, Barbara E K Klein, Ronald Klein.   

Abstract

PURPOSE: To investigate changes of vision-related quality of life during a 10-year period in a population with type 1 diabetes.
DESIGN: Prospective cohort study. PARTICIPANTS: Individuals who had their diabetes diagnosed before 30 years of age were considered to have type 1 diabetes (N = 1210). Those who participated in both 14-year (1995-1996) and 25-year (2005-2007) follow-up examinations were included in the current analysis (N = 471).
METHODS: Vision-related quality of life was measured with the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25). MAIN OUTCOME MEASURES: Changes in vision-related quality of life scores.
RESULTS: Loss of 3 lines in the Early Treatment Diabetic Retinopathy Study (ETDRS) chart was the most important factor related to negative changes in the NEI-VFQ-25 scores in our study after controlling for confounders. Most important changes were observed in subscales, such as general vision (-6.46 points), mental health (-10.19 points), role difficulty (-6.90 points), and driving (-10.43 points). Unemployment and the development of long-term complications, such as nephropathy, were also associated with negative changes in some NEI-VFQ-25 subscale scores. However, changes in diabetic retinopathy status were not related to changes in any subscale after 10 years.
CONCLUSIONS: Change in visual acuity was the most important factor associated with changes in vision-related quality of life scores in individuals with type 1 diabetes during a 10-year period. Our findings support the necessity of close follow-up of individuals with type 1 diabetes to avoid development of long-term complications and vision loss to improve quality of life.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20884058      PMCID: PMC3017211          DOI: 10.1016/j.ophtha.2010.06.022

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

2.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1989-02

3.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  R Klein; S E Moss; B E Klein; P Gutierrez; C M Mangione
Journal:  Arch Ophthalmol       Date:  2001-05

6.  Prevalence of diabetes mellitus in southern Wisconsin.

Authors:  R Klein; B E Klein; S E Moss; D L DeMets; I Kaufman; P S Voss
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

7.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

8.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

9.  Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.

Authors:  P G Tranos; F Topouzis; N T Stangos; S Dimitrakos; P Economidis; M Harris; A L Coleman
Journal:  Curr Eye Res       Date:  2004-07       Impact factor: 2.424

10.  The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.

Authors:  Louis S Matza; Matthew D Rousculp; Karen Malley; Kristina S Boye; Alan Oglesby
Journal:  Health Qual Life Outcomes       Date:  2008-11-07       Impact factor: 3.186

View more
  16 in total

1.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

Review 2.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

3.  The Association of Health-Related Quality of Life with Severity of Visual Impairment among People Aged 40-64 Years: Findings from the 2006-2010 Behavioral Risk Factor Surveillance System.

Authors:  John E Crews; Chiu-Fang Chou; Matthew M Zack; Xinzhi Zhang; Kai McKeever Bullard; Alan R Morse; Jinan B Saaddine
Journal:  Ophthalmic Epidemiol       Date:  2016-05-09       Impact factor: 1.648

Review 4.  Micro (mi) RNA and Diabetic Retinopathy.

Authors:  Praveen Sharma; Shailendra Dwivedi; Sunita Tiwari; Pankaj Kumar Singh; Amit Pal; Sandeep Kumar
Journal:  Indian J Clin Biochem       Date:  2022-01-14

Review 5.  Pathological eating behaviours and risk of retinopathy in diabetes: a systematic review and meta-analysis.

Authors:  Mike Trott; R Driscoll; E Iraldo; S Pardhan
Journal:  J Diabetes Metab Disord       Date:  2022-01-21

6.  Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.

Authors:  Rose A Gubitosi-Klug; Wanjie Sun; Patricia A Cleary; Barbara H Braffett; Lloyd Paul Aiello; Arup Das; William Tamborlane; Ronald Klein
Journal:  JAMA Ophthalmol       Date:  2016-02       Impact factor: 7.389

7.  Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK).

Authors:  Sobha Sivaprasad; Bhaskar Gupta; Martin C Gulliford; Hiten Dodhia; Samantha Mann; Dinesh Nagi; Jennifer Evans
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

8.  Investigating Factors Associated with Depression of Type 2 Diabetic Retinopathy Patients in China.

Authors:  Xujuan Xu; Xiaoyan Zhao; Duo Qian; Qing Dong; Zhifeng Gu
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

9.  Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema.

Authors:  Andrew J Lloyd; Jane Loftus; Michelle Turner; Ginny Lai; Andreas Pleil
Journal:  Health Qual Life Outcomes       Date:  2013-01-24       Impact factor: 3.186

10.  Modelling of diabetes knowledge, attitudes, self-management, and quality of life: a cross-sectional study with an Australian sample.

Authors:  Yee Cheng Kueh; Tony Morris; Erika Borkoles; Himanshu Shee
Journal:  Health Qual Life Outcomes       Date:  2015-08-19       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.